NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Forecast, Price & News

$199.10

-6.34 (-3.09%)

(As of 09/29/2023 ET)

Compare

Today's Range: $198.00
▼
$206.46
50-Day Range: $194.33
▼
$272.00
52-Week Range: $172.50
▼
$320.54

Volume: 567,130 shs
Average Volume: 483,527 shs
Market Capitalization: $7.32 billion

P/E Ratio: 31.01
Dividend Yield: N/A
Price Target: $283.00

Shockwave Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 42.1% Upside
$283.00 Price Target
Short Interest: Healthy
4.52% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.55
Upright™ Environmental Score
News Sentiment: 0.78
Based on 27 Articles This Week
Insider Trading: Selling Shares
$9.04 M Sold Last Quarter
Proj. Earnings Growth: 21.05%
From $3.61 to $4.37 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.86 out of 5 stars

Medical Sector

43rd out of 972 stocks

Surgical & Medical Instruments Industry

8th out of 99 stocks

3.4

Analyst's Opinion

Consensus Rating
Shockwave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $283.00, Shockwave Medical has a forecasted upside of 42.1% from its current price of $199.10.
Amount of Analyst Coverage
Shockwave Medical has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
4.52% of the outstanding shares of Shockwave Medical have been sold short.
Short Interest Ratio / Days to Cover
Shockwave Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Shockwave Medical has recently increased by 30.71%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Shockwave Medical does not currently pay a dividend.
Dividend Growth
Shockwave Medical does not have a long track record of dividend growth.

4.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Shockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for Shockwave Medical is -0.55.

2.1

News and Social Media Coverage

News Sentiment
Shockwave Medical has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 27 news articles for Shockwave Medical this week, compared to 6 articles on an average week.
Search Interest
Only 13 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -48% compared to the previous 30 days.
MarketBeat Follows
Only 7 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -13% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,044,874.00 in company stock.
Percentage Held by Insiders
Only 3.40% of the stock of Shockwave Medical is held by insiders.
Percentage Held by Institutions
87.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Shockwave Medical are expected to grow by 21.05% in the coming year, from $3.61 to $4.37 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Shockwave Medical is 31.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of Shockwave Medical is 31.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.20.
Price to Earnings Growth Ratio
Shockwave Medical has a PEG Ratio of 43.44. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Shockwave Medical has a P/B Ratio of 14.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Shockwave Medical (NASDAQ:SWAV) Stock

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Price History

30 days | 90 days | 365 days | Advanced Chart

SWAV Stock News Headlines

October 1, 2023 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Stock Price Down 2.3%

October 1, 2023 | americanbankingnews.com

UBS Group Initiates Coverage on Shockwave Medical (NASDAQ:SWAV)

October 1, 2023 | Oxford Club (Ad)

Better Than Oil Stocks

The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.

September 30, 2023 | msn.com

UBS Initiates Coverage of ShockWave Medical (SWAV) with Neutral Recommendation

September 29, 2023 | americanbankingnews.com

Shockwave Medical, Inc. (NASDAQ:SWAV) Insider Sells $768,480.00 in Stock

September 29, 2023 | americanbankingnews.com

Q3 2024 Earnings Forecast for Shockwave Medical, Inc. (NASDAQ:SWAV) Issued By Zacks Research

September 28, 2023 | benzinga.com

ShockWave Medical President Trades Company's Stock

September 28, 2023 | finance.yahoo.com

Insider Sell: Isaac Zacharias Sells 4,000 Shares of ShockWave Medical Inc

October 1, 2023 | Chaikin Analytics (Ad)

Something is Coming for America's Top Stock

This stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.

September 28, 2023 | americanbankingnews.com

Q2 2025 Earnings Forecast for Shockwave Medical, Inc. Issued By Zacks Research (NASDAQ:SWAV)

September 22, 2023 | finance.yahoo.com

Multiple Headwinds Pushed Shockwave Medical (SWAV) in Q2

September 22, 2023 | finance.yahoo.com

Multiple Tailwinds Pushed Shockwave Medical (SWAV) in Q2

September 22, 2023 | finance.yahoo.com

Director Frank Watkins Sells 3,000 Shares of ShockWave Medical Inc

September 21, 2023 | americanbankingnews.com

Douglas Evan Godshall Sells 10,000 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) Stock

September 19, 2023 | realmoney.thestreet.com

Don't Be Shocked if Shockwave Medical Keeps Heading South

September 12, 2023 | finance.yahoo.com

Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

September 11, 2023 | 247wallst.com

SWAV Stock Forecast: Riding the Sonic Wave of Innovation in Cardiovascular Treatment

September 11, 2023 | finance.yahoo.com

Shockwave Medical, Inc.'s (NASDAQ:SWAV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

September 6, 2023 | finance.yahoo.com

Here’s Why Shockwave Medical (SWAV) Outperformed in Q2

August 30, 2023 | benzinga.com

President of ShockWave Medical Sold $819K In Stock

August 25, 2023 | markets.businessinsider.com

Bank of America Securities Remains a Buy on Shockwave Medical (SWAV)

August 25, 2023 | markets.businessinsider.com

Piper Sandler Sticks to Their Buy Rating for Shockwave Medical (SWAV)

August 25, 2023 | finance.yahoo.com

Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Could Be 27% Above Their Intrinsic Value Estimate

August 24, 2023 | finance.yahoo.com

Shockwave Medical (SWAV) Exceeded Expectations in Q2

August 17, 2023 | finance.yahoo.com

More Convertible Bond Issuers Are Saying No to Hedging Their Bets

August 11, 2023 | msn.com

Shockwave Medical prices upsized private offering of $650M

August 11, 2023 | finance.yahoo.com

Shockwave Medical Prices Upsized Private Offering of $650.0 Million of 1.00% Convertible Senior Notes Due 2028

See More Headlines

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings: 8/07/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/06/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SWAV
CUSIP: N/A
CIK: 1642545
Web: www.shockwavemedical.com
Phone: (877) 775-4846
Fax: N/A
Employees: 1,001
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $283.00
High Stock Price Forecast: $330.00
Low Stock Price Forecast: $218.00
Forecasted Upside/Downside: +42.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): $6.42
Trailing P/E Ratio: 31.01
Forward P/E Ratio: 55.15
P/E Growth: 43.44
Net Income: $216 million
Net Margins: 39.56%
Pretax Margin: 24.90%
Return on Equity: 47.48%
Return on Assets: 36.24%

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 5.69
Quick Ratio: 4.54

Sales & Book Value

Annual Sales: $489.73 million
Price / Sales: 14.94
Cash Flow: $6.13 per share
Price / Cash Flow: 32.50
Book Value: $14.15 per share
Price / Book: 14.07

Miscellaneous

Outstanding Shares: 36,750,000
Free Float: 35,501,000
Market Cap: $7.32 billion
Optionable: Not Optionable
Beta: 0.98

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Douglas E. Godshall M.B.A. (Age 58)
Pres, CEO & Director
Comp: $1.57M

Mr. Daniel Puckett MBA (Age 59)
CFO, Principal Financial Officer & Sec.
Comp: $797.38k

Mr. Isaac Zacharias (Age 48)
Chief Commercial Officer
Comp: $908.02k

Mr. Daniel Hawkins (Age 56)
Founder and Sr. Advisor

Mr. John M. Adams (Age 76)
Co-Founder and Technical Advisor

Mr. Mike Maszy
Sr. VP of Operations

Ms. Trinh Phung (Age 45)
Chief Accounting Officer & Principal Accounting Officer

Mr. Hajime Tada J.D.
Gen. Counsel & Sec.

Mr. Robert Fletcher
Sr. VP of Marketing & Market Access

Mr. Dave Cox
VP of Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SWAV Stock - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?: 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SWAV shares.
View SWAV analyst ratings or view top-rated stocks.
What is Shockwave Medical's stock price forecast for 2023?: 8 Wall Street research analysts have issued 1-year target prices for Shockwave Medical's stock. Their SWAV share price forecasts range from $218.00 to $330.00. On average, they predict the company's share price to reach $283.00 in the next year. This suggests a possible upside of 42.1% from the stock's current price.
View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts.
How have SWAV shares performed in 2023?: Shockwave Medical's stock was trading at $205.61 on January 1st, 2023. Since then, SWAV shares have decreased by 3.2% and is now trading at $199.10.
View the best growth stocks for 2023 here.
Are investors shorting Shockwave Medical?: Shockwave Medical saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,660,000 shares, an increase of 30.7% from the August 31st total of 1,270,000 shares. Based on an average daily trading volume, of 524,000 shares, the days-to-cover ratio is presently 3.2 days.
View Shockwave Medical's Short Interest.
When is Shockwave Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our SWAV earnings forecast.
How were Shockwave Medical's earnings last quarter?: Shockwave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings results on Monday, August, 7th. The company reported $0.76 EPS for the quarter, missing analysts' consensus estimates of $0.85 by $0.09. The business had revenue of $180.17 million for the quarter, compared to analysts' expectations of $173.79 million. Shockwave Medical had a net margin of 39.56% and a trailing twelve-month return on equity of 47.48%. The business's revenue was up 49.2% on a year-over-year basis. During the same period last year, the company posted $0.68 earnings per share.
What ETFs hold Shockwave Medical's stock?: ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Alger Mid Cap 40 ETF (FRTY), WisdomTree U.S. Growth & Momentum Fund (WGRO) and First Trust Health Care AlphaDEX Fund (FXH).
What guidance has Shockwave Medical issued on next quarter's earnings?: Shockwave Medical issued an update on its FY 2023 earnings guidance on Monday, August, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $725.00 million-$730.00 million, compared to the consensus revenue estimate of $716.10 million.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?: 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.
What other stocks do shareholders of Shockwave Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).
When did Shockwave Medical IPO?: (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
What is Shockwave Medical's stock symbol?: Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."
How do I buy shares of Shockwave Medical?: Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Shockwave Medical's stock price today?: One share of SWAV stock can currently be purchased for approximately $199.10.
How much money does Shockwave Medical make?: Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $7.32 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $6.42 on an earnings per share basis.
How many employees does Shockwave Medical have?: The company employs 1,001 workers across the globe.
How can I contact Shockwave Medical?: Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Shockwave Medical (SWAV) Stock Forecast, Price & News

Shockwave Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Shockwave Medical (NASDAQ:SWAV) Stock

SWAV Price History

SWAV Stock News Headlines

SWAV Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SWAV Stock - Frequently Asked Questions

Overall MarketRank^™